Daily non-political popular news in brief.
Latest data shows MabThera provides significant, sustained relief from symptoms of RA
06-13-2007 · EurekAlert!New data presented at the EULAR meeting demonstrate that MabThera's effectiveness in relieving patients of the distressing symptoms of rheumatoid arthritis is sustained or further improved with subsequent courses of treatment, as is the number of patients achieving remission. Importantly, the safety profile of MabThera remained unchanged in patients who had received as many as seven courses of treatment at 6-12 month intervals.
Read more »
Keywords: latest, data, shows, mabthera, provides, significant, sustained, relief, symptoms, show, provide, symptom
« Previous | Next »
Similar news on "Latest data shows MabThera provides significant, sustained relief from symptoms of RA":
- Repeat treatment with MabThera provides continuous improvement of quality of life in RA patients
11-11-2006 · EurekAlert!
Data presented at this year's American College of Rheumatology Congress (ACR) show that patients receiving repeat treatment with MabThera/Rituxan (rituximab) achieved continued improvement in both physical and mental aspects of quality of life measures. In addition, a higher proportion of patients achieved a significant improvement in disease symptoms with a second course of MabThera, compared to the first course they received.
Similar news · Read more »
- Mayo Clinic study finds focused ultrasound treatment of uterine fibroids long term symptom relief
07-31-2007 · EurekAlert!
A noninvasive, outpatient treatment for noncancerous uterine tumors provides sustained relief from symptoms, according to a new Mayo Clinic led collaborative study.
Similar news · Read more »
- Phase 3 data show golimumab improved psoriatic arthritis symptoms
11-07-2007 · EurekAlert!
Patients with active psoriatic arthritis receiving monthly subcutaneous injections of golimumab experienced significant and sustained improvements in the joint and skin manifestations of the disease, according to findings from the largest phase 3 biologic study ever completed in subjects with psoriatic arthritis.
Similar news · Read more »
- Enbrel first biologic with up to 9 years rheumatoid arthritis safety, sustained efficacy data
11-13-2006 · EurekAlert!
Amgen (NASDAQ: AMGN) announced Enbrel (R) (etanercept) is the first biologic with published data to show sustained improvements in multiple efficacy measures in rheumatoid arthritis patients completing up to nine years of therapy. Current data suggest Enbrel is both effective and safe in long-term RA use, and the new data, presented at the American College of Rheumatology scientific meeting, provide a degree of reassurance that unexpected safety concerns do not appear to develop after nine years of use.
Similar news · Read more »
- Ski area affects mountain watershed, UVM study shows
05-17-2007 · EurekAlert!
In the first-ever study to document the effects of ski resort development on water flows and quality in the northeastern US, University of Vermont researchers studied side-by-side watersheds on Mount Mansfield. Their results show greater-than-expected water volume from the developed watershed, suggesting that models derived from timber extraction studies may underestimate the hydrologic effects of resort development. This study provides baseline data that may contribute to new stormwater management approaches in mountainside development.
Similar news · Read more »
- Enhanced MR-guided focused ultrasound guidelines demonstrate improved efficacy and durability
05-08-2007 · EurekAlert!
Data released today show that MR-guided focused ultrasound is a more effective option for a broader population of uterine fibroid sufferers. In a poster presented today at the American College of Obstetrics and Gynecology annual meeting in San Diego, Phyllis Gee, M.D. of the North Texas Uterine Fibroid Institute in Plano, Texas, showed that women undergoing MRgFUS experience rapid and sustained relief from their condition and have a reduced need for alternative, invasive treatments in the future.
Similar news · Read more »
- Brains scans of symptomatic Gulf War veterans show differences
05-01-2007 · EurekAlert!
Veterans of the first Gulf War who returned with multiple health symptom complaints show significant differences in brain structures from their fellow returnees without high numbers of health symptoms, according to research that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28-May 5, 2007.
Similar news · Read more »
- DAYTRANA (methylphenidate transdermal system) provides individualized ADHD symptom management
10-27-2006 · EurekAlert!
Shire's Attention Deficit Hyperactivity Disorder patch, DAYTRANA tm (methylphenidate transdermal system) has significant efficacy in reducing the symptoms of ADHD in children aged 6 to 12 years, even when removed earlier than the recommended nine hours. The ability to remove the patch earlier allows physicians the opportunity to manage potential late-day side effects, such as lack of appetite or difficulty sleeping, according to phase 3b trial results reported at a scientific child and adolescent psychiatry meeting in San Diego.
Similar news · Read more »
- Remicade data in ankylosing spondylitis show improvement in spinal mobility and spinal inflammation
06-15-2007 · EurekAlert!
Data presented today at the European League Against Rheumatism Annual European Congress of Rheumatology showed that patients with ankylosing spondylitis who received Remicade over two years experienced significant improvement in spinal mobility. In addition, Remicade-treated patients showed sustained reductions in spinal inflammation through two years as detected by magnetic resonance imaging.
Similar news · Read more »
- Individuals with high fear of crime twice as likely to suffer from depression
09-27-2007 · EurekAlert!
A new UCL study has shown that people with a strong fear of crime are almost twice as likely to show symptoms of depression. The research, based on data taken from the Whitehall II study, also shows that fear of crime is associated with decreased physical functioning and lower quality of life. The findings are published today in the American Journal of Public Health.
Similar news · Read more »
